Document is current
Any future updates will be listed below
-
Authors
Montgomery, John R. https://orcid.org/0000-0001-7751-231X
Seckin, Timur
Ghildayal, Nidhi https://orcid.org/0000-0002-7792-3431
Segev, Dorry L. https://orcid.org/0000-0002-1924-4801
Orandi, Babak J. https://orcid.org/0000-0001-6026-7135
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (K24AI144954)
- License Information
-
More Information
Article History
Accepted: 9 December 2024
First Online: 24 January 2025
Declarations
:
: Dr. Orandi reports the following disclosure: Boehringer Ingelheim (advisory board). Dr. Segev is a consultant to AstraZeneca, Novavax, Novartis, CareDx, Transmedics, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt and ThermoFisher Scientific, and reports honoraria from Sanofi, AstraZeneca, Optum, CareDx and Novartis, and grant support from the National Institutes of Health, all unrelated to the present work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
